BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 20975989)

  • 1. Regulation of pathologic retinal angiogenesis in mice and inhibition of VEGF-VEGFR2 binding by soluble heparan sulfate.
    Nishiguchi KM; Kataoka K; Kachi S; Komeima K; Terasaki H
    PLoS One; 2010 Oct; 5(10):e13493. PubMed ID: 20975989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiangiogenic antithrombin blocks the heparan sulfate-dependent binding of proangiogenic growth factors to their endothelial cell receptors: evidence for differential binding of antiangiogenic and anticoagulant forms of antithrombin to proangiogenic heparan sulfate domains.
    Zhang W; Swanson R; Xiong Y; Richard B; Olson ST
    J Biol Chem; 2006 Dec; 281(49):37302-10. PubMed ID: 17040907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparan sulfate regulates VEGF165- and VEGF121-mediated vascular hyperpermeability.
    Xu D; Fuster MM; Lawrence R; Esko JD
    J Biol Chem; 2011 Jan; 286(1):737-45. PubMed ID: 20974861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of the receptor binding profiles of the vascular endothelial growth factors on their angiogenic features.
    Nieminen T; Toivanen PI; Rintanen N; Heikura T; Jauhiainen S; Airenne KJ; Alitalo K; Marjomäki V; Ylä-Herttuala S
    Biochim Biophys Acta; 2014 Jan; 1840(1):454-63. PubMed ID: 24112971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apatinib, an Inhibitor of Vascular Endothelial Growth Factor Receptor 2, Suppresses Pathologic Ocular Neovascularization in Mice.
    Kim KL; Suh W
    Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3592-3599. PubMed ID: 28715845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble perlecan domain I enhances vascular endothelial growth factor-165 activity and receptor phosphorylation in human bone marrow endothelial cells.
    Muthusamy A; Cooper CR; Gomes RR
    BMC Biochem; 2010 Nov; 11():43. PubMed ID: 21047416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HSulf-1 inhibits angiogenesis and tumorigenesis in vivo.
    Narita K; Staub J; Chien J; Meyer K; Bauer M; Friedl A; Ramakrishnan S; Shridhar V
    Cancer Res; 2006 Jun; 66(12):6025-32. PubMed ID: 16778174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular endothelial growth factor upregulates expression of annexin A2 in vitro and in a mouse model of ischemic retinopathy.
    Zhao S; Huang L; Wu J; Zhang Y; Pan D; Liu X
    Mol Vis; 2009 Jun; 15():1231-42. PubMed ID: 19536308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thioredoxin-interacting protein deficiency ameliorates diabetic retinal angiogenesis.
    Duan J; Du C; Shi Y; Liu D; Ma J
    Int J Biochem Cell Biol; 2018 Jan; 94():61-70. PubMed ID: 29203232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiangiogenic effect of betaine on pathologic retinal neovascularization via suppression of reactive oxygen species mediated vascular endothelial growth factor signaling.
    Park SW; Jun HO; Kwon E; Yun JW; Kim JH; Park YJ; Kang BC; Kim JH
    Vascul Pharmacol; 2017 Mar; 90():19-26. PubMed ID: 27473515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor upregulates expression of ADAMTS1 in endothelial cells through protein kinase C signaling.
    Xu Z; Yu Y; Duh EJ
    Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):4059-66. PubMed ID: 16936124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
    Huang SW; Lien JC; Kuo SC; Huang TF
    Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrin-dependent and -independent functions of astrocytic fibronectin in retinal angiogenesis.
    Stenzel D; Lundkvist A; Sauvaget D; Busse M; Graupera M; van der Flier A; Wijelath ES; Murray J; Sobel M; Costell M; Takahashi S; Fässler R; Yamaguchi Y; Gutmann DH; Hynes RO; Gerhardt H
    Development; 2011 Oct; 138(20):4451-63. PubMed ID: 21880786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The interaction of heparan sulfate proteoglycans with endothelial transglutaminase-2 limits VEGF165-induced angiogenesis.
    Beckouche N; Bignon M; Lelarge V; Mathivet T; Pichol-Thievend C; Berndt S; Hardouin J; Garand M; Ardidie-Robouant C; Barret A; Melino G; Lortat-Jacob H; Muller L; Monnot C; Germain S
    Sci Signal; 2015 Jul; 8(385):ra70. PubMed ID: 26175493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
    Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
    Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiangiogenesis effects of endostatin in retinal neovascularization.
    Bai YJ; Huang LZ; Zhou AY; Zhao M; Yu WZ; Li XX
    J Ocul Pharmacol Ther; 2013 Sep; 29(7):619-26. PubMed ID: 23545016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Heparan Sulfate and Neuropilin 2 in VEGFA Signaling in Human Endothelial Tip Cells and Non-Tip Cells during Angiogenesis In Vitro.
    Dallinga MG; Habani YI; Schimmel AWM; Dallinga-Thie GM; van Noorden CJF; Klaassen I; Schlingemann RO
    Cells; 2021 Apr; 10(4):. PubMed ID: 33923753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knockout of αA-crystallin inhibits ocular neovascularization.
    Xu Q; Bai Y; Huang L; Zhou P; Yu W; Zhao M
    Invest Ophthalmol Vis Sci; 2015 Jan; 56(2):816-26. PubMed ID: 25574047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of choroidal neovascularization and quantitative and qualitative inhibition of VEGF and CCL2 by heparin.
    Tomida D; Nishiguchi KM; Kataoka K; Yasuma TR; Iwata E; Uetani R; Kachi S; Terasaki H
    Invest Ophthalmol Vis Sci; 2011 May; 52(6):3193-9. PubMed ID: 21296829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cultivated Orostachys japonicus extract inhibits VEGF-induced angiogenesis via regulation of VEGFR2 signaling pathway in vitro and in vivo.
    Cho HD; Lee KW; Won YS; Kim JH; Seo KI
    J Ethnopharmacol; 2020 Jun; 256():112664. PubMed ID: 32045685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.